Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franck Verrecchia

Showing results (31-40 of 72) with videos related to

Pageof 8
Sort By:
Oncotarget|May 28, 2015
Anticancer activity of halofuginone in a preclinical model of osteosarcoma: inhibition of tumor growth and lung metastasesAudrey Lamora, Mathilde Mullard, Jérôme Amiaud, et al.
Biochemical Pharmacology|October 22, 2021
Ubiquitin-specific proteases as therapeutic targets in paediatric primary bone tumours?Mathilde Mullard, Mélanie Lavaud, Laura Regnier, et al.
Journal of Clinical Medicine|November 10, 2016
TGF-β Signaling in Bone Remodeling and Osteosarcoma ProgressionAudrey Lamora, Julie Talbot, Mathilde Mullard, et al.
Cancers|July 27, 2022
Origin and Therapies of OsteosarcomaBrice Moukengue, Morgane Lallier, Louise Marchandet, et al.
The Journal of Biological Chemistry|August 18, 2006
Modulation of collagen and MMP-1 gene expression in fibroblasts by the immunosuppressive drug rapamycin. A direct role as an antifibrotic agent?Nicolas Poulalhon, Dominique Farge, Nina Roos, et al.
Cells|April 3, 2021
Molecular Chaperones in Osteosarcoma: Diagnosis and Therapeutic IssuesMorgane Lallier, Louise Marchandet, Brice Moukengue, et al.
Molecular Carcinogenesis|November 1, 2008
c-Fos accelerates hepatocyte conversion to a fibroblastoid phenotype through ERK-mediated upregulation of paxillin-Serine178 phosphorylationMeryem C Güller, Jocelyne André, Agnès Legrand, et al.
Epigenomics|April 8, 2024
Super-enhancers: drivers of cells' identities and cells' debaclesMélanie Lavaud, Robel Tesfaye, Léa Lassous, et al.
Cancers|November 26, 2022
TRAIL-Based Therapies Efficacy in Pediatric Bone Tumors Models Is Modulated by TRAIL Non-Apoptotic Pathway Activation via RIPK1 RecruitmentRégis Brion, Malika Gantier, Kevin Biteau, et al.
European Journal of Cell Biology|February 12, 2017
Analysis of gap junctional intercellular communications using a dielectrophoresis-based microchipMarta Tellez-Gabriel, Céline Charrier, Bénédicte Brounais-Le Royer, et al.
Pageof 8

Showing results (31-40 of 72) with videos related to

Sort By:
Pageof 8
Oncotarget|May 28, 2015
Anticancer activity of halofuginone in a preclinical model of osteosarcoma: inhibition of tumor growth and lung metastasesAudrey Lamora, Mathilde Mullard, Jérôme Amiaud, et al.
Biochemical Pharmacology|October 22, 2021
Ubiquitin-specific proteases as therapeutic targets in paediatric primary bone tumours?Mathilde Mullard, Mélanie Lavaud, Laura Regnier, et al.
Journal of Clinical Medicine|November 10, 2016
TGF-β Signaling in Bone Remodeling and Osteosarcoma ProgressionAudrey Lamora, Julie Talbot, Mathilde Mullard, et al.
Cancers|July 27, 2022
Origin and Therapies of OsteosarcomaBrice Moukengue, Morgane Lallier, Louise Marchandet, et al.
The Journal of Biological Chemistry|August 18, 2006
Modulation of collagen and MMP-1 gene expression in fibroblasts by the immunosuppressive drug rapamycin. A direct role as an antifibrotic agent?Nicolas Poulalhon, Dominique Farge, Nina Roos, et al.
Cells|April 3, 2021
Molecular Chaperones in Osteosarcoma: Diagnosis and Therapeutic IssuesMorgane Lallier, Louise Marchandet, Brice Moukengue, et al.
Molecular Carcinogenesis|November 1, 2008
c-Fos accelerates hepatocyte conversion to a fibroblastoid phenotype through ERK-mediated upregulation of paxillin-Serine178 phosphorylationMeryem C Güller, Jocelyne André, Agnès Legrand, et al.
Epigenomics|April 8, 2024
Super-enhancers: drivers of cells' identities and cells' debaclesMélanie Lavaud, Robel Tesfaye, Léa Lassous, et al.
Cancers|November 26, 2022
TRAIL-Based Therapies Efficacy in Pediatric Bone Tumors Models Is Modulated by TRAIL Non-Apoptotic Pathway Activation via RIPK1 RecruitmentRégis Brion, Malika Gantier, Kevin Biteau, et al.
European Journal of Cell Biology|February 12, 2017
Analysis of gap junctional intercellular communications using a dielectrophoresis-based microchipMarta Tellez-Gabriel, Céline Charrier, Bénédicte Brounais-Le Royer, et al.
Pageof 8